Isthmus Partners LLC Buys 105 Shares of Teleflex Incorporated (NYSE:TFX)

Isthmus Partners LLC increased its stake in Teleflex Incorporated (NYSE:TFX) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,535 shares of the medical technology company’s stock after buying an additional 105 shares during the quarter. Isthmus Partners LLC’s holdings in Teleflex were worth $273,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Janney Montgomery Scott LLC increased its stake in Teleflex by 0.4% in the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after purchasing an additional 65 shares during the period. Robeco Institutional Asset Management B.V. purchased a new stake in Teleflex in the third quarter worth $687,000. QRG Capital Management Inc. purchased a new stake in Teleflex in the third quarter worth $509,000. Principal Financial Group Inc. increased its stake in Teleflex by 2.7% in the third quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock worth $19,887,000 after purchasing an additional 2,086 shares during the period. Finally, Verdence Capital Advisors LLC increased its stake in Teleflex by 6.4% in the third quarter. Verdence Capital Advisors LLC now owns 1,622 shares of the medical technology company’s stock worth $401,000 after purchasing an additional 97 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

TFX opened at $138.40 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market capitalization of $6.42 billion, a PE ratio of 27.51, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The business’s 50-day moving average is $170.36 and its two-hundred day moving average is $200.33. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TFX. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Wells Fargo & Company cut their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Finally, Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and cut their price target for the company from $220.00 to $155.00 in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.